WAM
11 Jun 2022, 19:40 GMT+10
BEIJING, 11th June, 2022 (WAM) -- Two mRNA-based COVID-19 vaccine candidates produced by Chinese manufacturer CanSino Biologics have proven effective in preclinical trials, suggesting the potential for human tests, according to a new study published in the journal Emerging Microbes & Infections.
Results showed that the two vaccines, the mRNA-Beta and mRNA-Omicron, can induce high-titer neutralising antibody levels against original and multiple SARS-CoV-2 variants, such as Beta, Delta and Omicron, reported the Chinese news agency, Xinhua.
Two doses of mRNA-Beta could induce broad protection especially for Beta and original variants. Meanwhile, mRNA-Omicron was suggested as a booster injection in mice vaccinated with primary mRNA-Beta or Ad5-nCoV, the company's recombinant COVID-19 vaccine, to offer further protection against Omicron variant, according to the study.
The Chinese mRNA vaccines got clinical trial approval in April and they have entered phase-1 human trials, according to a company statement released this week.
Compared with traditional vaccine technologies, the mRNA technology has the advantage of a shorter development and production cycle.
The Chinese vaccine maker said an industrialisation base of the COVID-19 mRNA vaccine was under construction in Shanghai. It will enable the annual production capacity to reach 100 million doses by the end of 2022.
Get a daily dose of Beijing Bulletin news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Beijing Bulletin.
More InformationMOUNTAIN VIEW, California: To settle a major shareholder lawsuit, Google is writing a US$500 million check — not for damages, but to...
DUBLIN, Ireland: TikTok is asking the High Court to stop a decision that could block the transfer of user data to China within six...
Tech forum delegates have discussed joint efforts on trade, AI, cybersecurity, and innovation with RT Russia and the Global South...
* As for Trump's post saying Musk wearing thin and going crazy, Musk described the post as Such an obvious lie. So sad. * Following...
Washington DC [US], June 6 (ANI): US Vice President JD Vance has extended support to US President Donald Trump amid the public breakdown....
Dehradun (Uttarakhand) [India], June 6 (ANI): The Governor of Uttarakhand has given approval for the formation of a Strategic Advisory...
NEW YORK, New York - U.S. stocks rose appreciably Friday following the release of a strong jobs report which sent the U.S. dollar higher,...
WASHINGTON, D.C. America's job market is starting to lose momentum. In April, job openings rose — but so did layoffs, marking their...
DUBLIN, Ireland: Digital Business Ireland (DBI) has asked the Government to do more to help Ireland's digital and tech sector. This...
TOKYO, Japan: Toyota has announced that it will take one of its key group suppliers, Toyota Industries, private in a deal worth UD$26...
NEW YORK, New York - U.S. stocks fell Thursday after the feud between U.S. President Donald Trump and his biggest backer Elon Musk...
SYDNEY, Australia: Australia's independent wage-setting body, the Fair Work Commission (FWC), has announced a 3.5 percent increase...